Works matching IS 18817815 AND DT 2024 AND VI 18 AND IP 6

Results: 11

mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 599, doi. 10.5582/bst.2024.01286

By:

Zhipeng Sun;
Hai Xu;
Lei Yang;
Xiaojuan Wang;
Bin Shu;
Ming Yang;
Zhizhong Ren;
Canhong Xiang;
Yuewei Zhang;
Shizhong Yang

Publication type:

Article

Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: Stratified analysis based on tumor burden score.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 584, doi. 10.5582/bst.2024.01277

By:

Hongxin Li;
Junjie Kong;
Wei Si;
Tao Wang;
Min Ji;
Guangbing Li;
Jun Liu

Publication type:

Article

The APP Score: A simple serum biomarker model to enhance prognostic prediction in hepatocellular carcinoma.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 576, doi. 10.5582/bst.2024.01228

By:

Jinyu Zhang;
Qionglan Wu;
Jinhua Zeng;
Yongyi Zeng;
Jingfeng Liu;
Jianxing Zeng

Publication type:

Article

Repeat laparoscopic hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: A multicenter, propensity score matching analysis.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 563, doi. 10.5582/bst.2024.01224

By:

Zihui Ma;
Xiaolu Lin;
Jinglei Zhang;
Xingchao Song;
Maolin Yan;
Lei Guo;
Jie Xue;
Chongde Lu;
Jie Shi;
Shuqun Cheng;
Weixing Guo

Publication type:

Article

First-line systemic therapy and sequencing options in advanced biliary tract cancer: A systematic review and network metaanalysis.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 555, doi. 10.5582/bst.2024.01376

By:

Ranning Xu;
Jian Zhou;
Jian Yang;
Yanxi Yu;
Hao Wang;
Ziqi Zhang;
Guo Zhang;
Rui Liao

Publication type:

Article

Machine learning-based prognostic prediction and surgical guidance for intrahepatic cholangiocarcinoma.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 545, doi. 10.5582/bst.2024.01312

By:

Long Huang;
Jianbo Li;
Shuncang Zhu;
Liang Wang;
Ge Li;
Junyong Pan;
Chun Zhang;
Jianlin Lai;
Yifeng Tian;
Shi Chen

Publication type:

Article

Development and validation of a machine-learning model to predict lymph node metastasis of intrahepatic cholangiocarcinoma: A retrospective cohort study.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 535, doi. 10.5582/bst.2024.01282

By:

Shizheng Mi;
Guoteng Qiu;
Zhihong Zhang;
Zhaoxing Jin;
Qingyun Xie;
Ziqi Hou;
Jun Ji;
Jiwei Huang

Publication type:

Article

Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 505, doi. 10.5582/bst.2024.01394

By:

Haowen Tang;
Wenwen Zhang;
Junning Cao;
Yinbiao Cao;
Xinyu Bi;
Haitao Zhao;
Ze Zhang;
Zhe Liu;
Tao Wan;
Ren Lang;
Wenbing Sun;
Shunda Du;
Yongping Yang;
Yinying Lu;
Daobing Zeng;
Jushan Wu;
Binwei Duan;
Dongdong Lin;
Fei Li;
Qinghua Meng

Publication type:

Article

Advances in systemic therapy leading to conversion surgery for advanced hepatocellular carcinoma.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 525, doi. 10.5582/bst.2024.01372

By:

Hiroyuki Hakoda;
Akihiko Ichida;
Kiyoshi Hasegawa

Publication type:

Article

Applications of and issues with machine learning in medicine: Bridging the gap with explainable AI.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 497, doi. 10.5582/bst.2024.01342

By:

Kenji Karako;
Wei Tang

Publication type:

Article

Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.

Published in:

BioScience Trends, 2024, v. 18, n. 6, p. 495, doi. 10.5582/bst.2024.01423

By:

Peipei Song;
Wei Tang;
Norihiro Kokudo

Publication type:

Article